Showing results (251-260 of 283) with videos related to
Sort By:
Pageof 29
International Journal of Radiation Oncology, Biology, Physics|June 13, 2012
A phase I study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomasRobert B Den, Mitchell Kamrava, Zhi Sheng, et al.Journal of Neuro-Oncology|January 10, 2018
Correction to: Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatmentWenyin Shi, Erik S Blomain, Joshua Siglin, et al.Frontiers in Oncology|May 16, 2022
Scalp-Sparing Radiation With Concurrent Temozolomide and Tumor Treating Fields (SPARE) for Patients With Newly Diagnosed GlioblastomaRyan Miller, Andrew Song, Ayesha Ali, et al.Lancet (London, England)|May 26, 2004
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trialDavid W Andrews, Charles B Scott, Paul W Sperduto, et al.Journal of Neuro-Oncology|April 28, 2011
Safety and feasibility of motexafin gadolinium administration with whole brain radiation therapy and stereotactic radiosurgery boost in the treatment of ≤ 6 brain metastases: a multi-institutional phase II trialDerek R McHaffie, Pierre Chabot, Anne Dagnault, et al.Journal of Neuro-Oncology|September 6, 2018
Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?Joshua D Palmer, Deepak Bhamidipati, Andrew Song, et al.Neurosurgery|September 18, 2002
Fractionated stereotactic radiotherapy for the treatment of optic nerve sheath meningiomas: preliminary observations of 33 optic nerves in 30 patients with historical comparison to observation with or without prior surgeryDavid W Andrews, Rod Faroozan, Benson P Yang, et al.International Journal of Radiation Oncology, Biology, Physics|February 9, 2013
A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320Paul W Sperduto, Meihua Wang, H Ian Robins, et al.Archives of Oral Biology|October 6, 2017
Anti-inflammatory effect of an adhesive resin containing indomethacin-loaded nanocapsulesBruna Genari, Maria Beatriz Cardoso Ferreira, Liciane Fernandes Medeiros, et al.Frontiers in Oncology|March 29, 2021
Initial Clinical Experience of MR-Guided Radiotherapy for Non-Small Cell Lung CancerCathryn B Crockett, Pamela Samson, Robert Chuter, et al.Pageof 29